Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

about

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

Item

http://www.wikidata.org/entity/Q50908320

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

@en

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

@nl

type

Item

label

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

@en

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

@nl

prefLabel

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

@en

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

@nl

P1476

Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.

@en

P2093

Laurence H Beck

http://www.w3.org/2001/XMLSchema#string

Meryl Waldman

http://www.w3.org/2001/XMLSchema#string

Peter D Burbelo

http://www.w3.org/2001/XMLSchema#string

P2860

The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins

Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate

Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy

Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes.

An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.

Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.

Anti-phospholipase A2 receptor antibody in membranous nephropathy.

P304

17-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JIM.2017.02.001

http://www.w3.org/2001/XMLSchema#string

P478

444

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28167276

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody

P932

5376496

http://www.w3.org/2001/XMLSchema#string